Clinical Trials

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04906876 2021-07-28

A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas

Sarcoma

Bone Neoplasms, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT04260360 2020-08-04

Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02451865 2020-07-24

Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT02831491 2020-06-09

A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT03811418 2019-11-26

ATTILA

Phase 3 Withdrawn

Tumor-Agnostic

Neoplasm Metastasis

NCT02182622 2019-06-19

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

Prostatic Neoplasms

NCT03343977 2018-07-17

Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Metastatic Hormone-Sensitive Prostate Cancer

NCT02793765 2017-10-30

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Neoplasm Metastasis, Prostatic Neoplasms

NCT02651610 2017-07-11

Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms

NCT00937417 2017-04-24

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

BreastCNSEndocrineGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

NCT01087580 2017-03-03

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Prostatic Neoplasms

NCT00452920 2016-12-15

Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer

Gynecologic

Uterine Cervical Neoplasms

NCT00598858 2016-12-08

2007-5904

Prostatic Neoplasms

NCT00774241 2016-11-02

PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer

Phase 4 Withdrawn

Breast Neoplasms

NCT00964704 2016-11-02

A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

Breast Neoplasms

NCT02083536 2016-08-10

LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma

Gynecologic

Ovarian Neoplasms

NCT02522910 2016-08-10

An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

BreastCNSGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung

NCT00041171 2016-07-12

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Phase 3 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT01245543 2015-11-02

Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors

Other solid neoplasm

Solid Tumors

NCT02536495 2015-10-30

Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer

Recurrent Squamous Cell Lung Carcinoma

NCT00755157 2015-10-07

Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer

Neoplasms, Small Cell Lung Carcinoma

NCT01071928 2015-08-19

Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma

Carcinoma, Transitional Cell

NCT00697060 2015-06-24

A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02120118 2015-06-09

Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors

Other solid neoplasm

Solid Tumors

NCT01562301 2015-06-08

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00471159 2015-05-04

A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.

Breast Neoplasms

NCT00678626 2015-05-04

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Breast Diseases, Breast Neoplasms

NCT01938456 2014-07-28

Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT00313690 2014-05-21

Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer

Lung Neoplasms

NCT01907308 2014-04-29

Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00074139 2014-03-05

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer

Breast Neoplasms

NCT01137994 2013-03-13

A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer

Breast Neoplasms

NCT01478308 2013-03-06

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

Prostatic Neoplasms

NCT00386555 2012-08-09

A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

Carcinoma, Non-Small-Cell Lung

NCT00048087 2012-07-31

Iressa/Docetaxel in Non-Small-Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT00434031 2012-07-30

CETRA

Breast Neoplasms

NCT00811031 2012-07-30

Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)